Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Corporate Headquarters
280 Utah Avenue, Suite 275
South San Francisco, CA, 94080
USA

People

Board of Directors

Funding

TOTAL $32M
FUNDING TOTAL $32M
Series C, 12/2007
Wellington Partners
$12M
Series D, 6/2008
$20M

Tags

CoMentis

CoMentis is a biotech company focused on the research and development of small molecule drugs to treat neurovascular diseases such as Alzheimer’s disease (AD), age-related macular degeneration (AMD) and other cognitive disorders. Originally founded in 2004 as Athenagen, Inc., the company was re-named CoMentis following its August 2006 merger with Zapaq, Inc., which created a leading neurovascular disease franchise.

Recent Milestones

Videos

Screenshots

CoMentis screenshot
Above: CoMentis
Uploaded: 6/27/09

Sources

  1. CoMentis gets $12M for eye, Alzheimer’s treatments (venturebeat.com) [edit]
  2. CoMentis raises $20 million for Alzheimer’s drugs (venturebeat.com) [edit]
Edit This Page
Last Edited 1/3/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy